Silodosin 8 mg
Sponsors
Watson Pharmaceuticals, Ain Shams University, Kaohsiung Medical University Chung-Ho Memorial Hospital, Atlantic Health System, Beni-Suef University
Conditions
Abacterial Chronic Prostatitis/Chronic Pelvic Pain SyndromeAcute Urinary RetentionBenign Prostatic HyperplasiaChoroidFemale LUTSHuman TrichinellosisIntraoperative Floppy Iris SyndromeIris Disease
Phase 2
Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
CompletedNCT00740779
Start: 2008-09-30End: 2009-10-31Updated: 2012-02-24
A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding Dysfunction
Not yet recruitingNCT07822113
Start: 2026-10-01End: 2027-12-01Target: 150Updated: 2026-09-16
Phase 3
Phase 4
Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
RecruitingNCT07614321
Start: 2026-04-01End: 2028-04-01Target: 60Updated: 2026-05-29
Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention
RecruitingNCT07650968
Start: 2026-06-08End: 2027-06-01Target: 378Updated: 2026-06-16
Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
Not yet recruitingNCT07743060
Start: 2026-08-01End: 2027-04-01Target: 40Updated: 2026-08-03
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
Not yet recruitingNCT07743034
Start: 2026-08-01End: 2027-04-01Target: 40Updated: 2026-08-03